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ABSTRACT  
 
Study Question: 
Does a logistic regression model and scoring system to predict viability of an intrauterine 
pregnancy of uncertain viability (PUV) perform as well in an independent patient group as the 
original patient group?  
 Summary Answer: 
The model and scoring system showed good performance on external validation confirming 
their value for the  prediction of miscarriage/viability in PUV patients up to 11 to 14 weeks 
gestation. A new model and scoring system without gestational age showed reasonable test 
performance and form a valuable alternative when patients are not able to report their LMP. 
 
What is known already: 
Several individual ultrasound and demographic factors have been described as predictors for 
miscarriage. A logistic regression model and simple scoring system using basic clinical and 
ultrasound features such as maternal age, bleeding score, mean gestational sac diameter (MSD) 
and presence or absence of yolk sac have been developed to allow patient specific prediction 
of viability of PUV beyond the first trimester. 
 
Study Design, size, duration: 
Prospective observational external validation cohort study in two inner city early pregnancy 
assessment units over a period of 18 months.  
 
Participants/materials, setting, methods: 
All consecutive women with a PUV were recruited. Ultrasound (mean sac diameter and 
presence of yolk sac)  and demographic variables (maternal age, bleeding score and gestational 
age) were noted. The outcome measure was first trimester (11 -14 week)  viability. Women 
with unknown first trimester outcome were excluded. Receiver operating characteristics (ROC) 
curves and calibration plots were constructed. Test performance was compared to the original 
development dataset.  A new model and scoring system, which did not include gestational age, 
was built and evaluated. 
 
Main results and the role of chance:  
575 women were recruited. Outcome was known for 89.2%. The model could only be validated 
in 400 patients, due to missing values in model variables and output.   The model predicted 
viability with an area under the ROC Curve (AUC) of 0.845 (95% CI, 0.806-0.884) compared 
to 0.774 (95% CI, 0.701-0.848) in the original study. The AUC for the scoring system was 
0.832 (95% CI, 0.792-0.872) compared to 0.771 (95% CI, 0.698–0.844) from the original study 
dataset. The new model and the scoring system, excluding gestational age, could be evaluated 
on 503 patients and  resulted in an AUC of 0.801 (95% CI, 0.762-0.841) for the model and  
0.773 (95% CI, 0.733-0.812) for the scoring system.  
 
Limitations, reasons for caution: 
Approximately 22% patients could not be validated due to missing variables and 11% patients 
did not have their first trimester outcome.   
 
Wider implications of the findings: 
Both the model and the scoring system showed excellent performance on external validation 
confirming their generalisability and utility in prediction of viability beyond the first trimester 
clinical practice.   
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INTRODUCTION 
 
In a systematic review of the accuracy of first trimester ultrasound for the diagnosis of early 
embryonic demise, Jeve et al found that there was a paucity of high quality prospective data on 
which to base guidance (1). Three further recent publications suggested that criteria used to 
define miscarriage based on transvaginal scan (TVS) measurements of gestation sac and 
embryo size were unreliable (2,3,4). This new information led to the Royal College of 
Obstetricians and Gynaecologists (RCOG) in the United Kingdom amending their guidance 
such that on a single TVS a miscarriage can only be diagnosed when an empty gestation sac is 
> 25mm in mean diameter or when the crown-rump length (CRL) measurement for an embryo 
with no visible heartbeat is > 7.0 mm. The guidance emphasised the need for repeating 
ultrasound scans at an interval in order to definitively comment on viability (5). At a consensus 
meeting of the Society of Radiologists in Ultrasound (SRU) in 2012 it was concluded that 
similar guidance should be adopted in the United States. Whilst this more conservative 
approach to the diagnosis of miscarriage is welcomed, it is likely to be associated with more 
pregnancies being classified as being of uncertain viability. The introduction of sensitive home 
pregnancy tests means women may have a positive pregnancy test even before they have missed 
a period. The result of these developments means women attending for TVS in early pregnancy 
are more likely to have an uncertain outcome and be asked to undergo a repeat examination at 
an interval of 7 -14 days.  
 
We know that early pregnancy complications may lead to significant psychological morbidity 
(6). The uncertainty of waiting for repeat examinations may compound what is already a 
anxious situation for couples, furthermore there is often a reluctance to accept that definitive 
answers cannot always be given at a single visit. It is helpful to counsel women about the 
probable outcome of the pregnancy so they are better prepared for the likely findings when they 
return to the clinic.  
 
Anxiety also arises when a pregnancy is found to be smaller than expected for the menstrual 
dates given by the patient. This may be an innocent finding and relate to variations in both the 
timing of ovulation and implantation (7). However it has been appreciated that a difference in 
embryonic size from that expected may reflect a higher risk of miscarriage or aneuploidy (8). 
For other women the discrepancy between expected and observed embryo measurements may 
be because they have irregular periods or do not accurately remember the date of their last 
menstrual period (LMP).  Giving appropiate advice to women about the possible outcome of 
their pregnancy in these circumstances is important to avoid unrealistic expectations.  
 
To address some of these issues we have previously described a mathematical model (Mo) and 
simple scoring system (SSo) to predict the outcome of a pregnancy when it is classified as an 
intrauterine pregnancy of uncertain viability (PUV) (9). Both the model (Mo) and the scoring 
system (SSo) provide an individualized probability of pregnancy viability depending on 
maternal age, the amount of vaginal bleeding, gestational age, the mean gestational sac diameter 
and visibility of a yolk sac. This model (Mo)  and scoring system (SSo) were developed on data 
from one hospital unit, and showed very good prediction of viability on internal validation. 
However before introducing a test into routine clinical practice it is necessary to demonstrate a 
good performance in different settings and populations.  
 
In the present study we carried out an external validation to test the performance of both the 
model (Mo) and scoring system (SSo). The two units are inner London hospitals with large 
clinical throughputs and ethnically diverse populations.  We also approached the problem of 
how to include women who are uncertain about the date of their LMP in the prediction model. 
We therefore used the training set from the original paper (9) to develop a new model (Mn) and 
scoring system (SSn) that did not take gestational age into account. This model and the scoring 
system were then tested on both the original and external validation data. 
 
MATERIALS AND METHODS 
 
This was an 18 months multicentre prospective cohort study (January 2011 – July 2012) in the 
early pregnancy assessment units of Chelsea and Westminster Hospital (C&W) and Queen 
Charlottes and Chelsea Hospital, Imperial College, London (QCCH). Both units take referrals 
from primary care physicians, emergency units and other departments in the hospital. There is 
no minimum gestational age criteria for attendance.  
 
Inclusion criteria for the study were: all women classifed as having an intrauterine pregnancy 
of uncertain viability (PUV). A PUV was defined using the following criteria on the basis of a 
TVS: 
The visualisation of  a single intrauterine gestational sac with a mean gestation sac diameter 
(MSD) of  ≤ 20mm  at C&W (prior to September 2011)  and ≤ 25mm at QCCH, with or without 
a visible yolk sac, or a single intrauterine gestational sac with a visible embryo of ≤6mm  at 
C&W (prior to September 2011) and ≤7mm at QCCH but no embryonic heart beat. Exclusion 
criteria were women with multiple pregnancies and those who underwent termination of 
pregnancy. 
 
Prior to the consultation, the women completed a written questionnaire which included the date 
of their LMP, previous obstetric history and pregnancy symptoms. This information was 
confirmed by the examining sonographer. The amount of vaginal bleeding was estimated using 
a pictorial bleeding assessment chart (PBAC) (10).  The bleeding score ranged from 0 (no 
bleeding) to 4 (bleeding with clots).  
 All women underwent a TVS performed by an appropriately trained examiner (a nurse 
specialist, gynecologist or sonographer) using either  Voluson E8 Expert (GE healthcare, 
Wisconsin, USA) or Medison Accuvix XG (Samsung Medison, Seoul, South Korea) 
ultrasound machine using a tight curvilinear transvaginal probe operating at a frequency of 3.5 
– 9.3 MHz.  Structured assessment consisted of measurements of the gestational sac and yolk 
sac in three orthogonal planes and measurement of the crown-rump length of the embryo if 
present. All images were stored in the Picture Archiving and Communication System (PACS) 
or as hard copies in the patient’s casenotes. The measurements were reported using 
commercially available ultrasound databases (Radcentre (iSOFT – IBA healthgroup company) 
and  Astraia (astraia software gmbh, Munich, Germany). 
 
All women included were scheduled to have a repeat TVS examination after 7 to 14 days. The 
outcome of interest was viability at the routine  end of first trimester scan (11 to 14 weeks 
gestation).  
 
 
 
  
Statistical Analysis 
 
In our validation study, only the five variables included in the previously developed model were 
recorded. In the original model, univariable and multivariable logistic regression analysis were 
performed to establish relationship between first trimester viability and a number variables like 
maternal age, ethnicity, obstetric history, gestational age by LMP, abdominal pain, pain score, 
presence of vaginal bleeding, bleeding score, mean sac diameter, presence of yolk sac, mean 
yolk sac diameter and subchorionic hematoma. Multivariable models were developed with the 
significant variables, using a stepwise approach (9). These were maternal age, gestational age 
(calculated from LMP), PBAC, mean gestation sac diameter and presence or absence of a yolk 
sac.  For both the mathematical model (Mo) and simple scoring system (SSo), a receiving 
operating characteristics (ROC) curve was constructed to describe the relationship between the 
sensitivity and the false-positive rate (1 – specificity) to predict ongoing viability. Calibration 
plots, plotting the observed versus the predicted probability of viability for both the 
mathematical model and the scoring system, were constructed.  
 
As the model and the scoring system could not be used in women with unknown LMP, a new 
mathematical model (Mn) and scoring system (SSn) were developed on the training set of the 
original cohort. This model and scoring system were dependent on four variables which were 
maternal age, PBAC, mean sac diameter and presence or absence of a yolk sac. The new model 
(Mn) and the scoring system (SSn) were applied to the original test set, and further tested on this 
new external validation dataset.  
 
 
 
 
 
  
RESULTS  
 
During this study period 575 consecutive women with a PUV were recruited. The outcome was 
known in 513 (89.2%) pregnancies. 260/513 (50.7%) pregnancies were viable and  253/513 
(49.3%) non-viable at the end of the first trimester. Analysis was performed on all 400 patients 
for whom all covariates and the outcome were known.  Most exclusions (n=103) were due to 
unknown LMP.  The bleeding score and presence of the yolk sac was unknown for 9 and 2 
pregnancies, respectively wherein 1 patient had both variables missing. Of these 400 
pregnancies, 200 (50%) were viable at the end of first trimester.  The data collection method is 
shown in figure 1.Patients who miscarried either had heavy bleeding in the interim with no 
pregnancy visualised on the follow up scan at 7 to 14 days, had  a non-viable pregnancy 
diagnosed at a 7-14 day follow up scan or had a viable pregnancy at the follow up scan but 
subsequently miscarried before the end of the first trimester. 
 
The model (Mo) was defined as  
 
z 9 0.27  maternal age  0.4  PBAC score  1.3  (gestational age  42 days) 
     0.09  ( MSD  7 )  1.3  (yolk sac present),
= − × − × + × <
− × − + ×
 
where maternal age is taken to be 35 when the age is less than 35. The estimated chance of a 
viable pregnancy is then obtained as exp( ) / (1 exp( ))z z+ .  On the new external validation set, 
this model obtained an area under the ROC curve (AUC) of 0.845 (95% CI 0.806-0.884). The 
scoring system (SSo) obtained an AUC of 0.832 (95% CI 0.792-0.872) in the same set. The 
ROC curves of both the model and the scoring system are illustrated in Figure 2. 
 
Since patients are often unable to report an LMP, and the original model is not able to obtain a 
risk estimate for these patients, a new model (Mn) and scoring system (SSn) that did not include 
information on LMP,  were built using the training set from (9).  The resulting model is defined 
as 
 
10.87 0.29  maternal age  1.03 PBAC score   0.13  ( MSD  7 ) 
      0.77  (yolk sac present) 0.91  PBAC score   (yolk sac present),
z = − × − × − × −
+ × + × ×
 
where maternal age was again taken to be 35 when age is less than 35.  The chance was obtained 
as before.  This model was validated on 503 patients with known outcome and covariates of the 
external validation set.    The model obtained an AUC of 0.801 (95% CI=0.765-0.841) on the 
new external validation set.  Since the information on LMP is not taken into account, the 
performance is less than for the original model.   
To facilitate application of the model Mn, a scoring system was derived from the new model as 
in the original study (9,11).  Table 1 summarizes the new score system SSn.  The score system 
obtained an AUC of 0.773 (95% CI=0.733-0.812) on the new external validation data.  The 
ROC curves for the new model and scoring system are given in Figure 3.  Calibration plots (not 
shown) illustrate that the models and score systems are well calibrated, indicating that the 
chance predicted by the model corresponds to the chance observed in the dataset.   
 
For clinical practice, we propose to use the original model Mo or scoring system SSo whenever 
the patient reports an LMP, and to use the new model Mn or scoring system SSn otherwise.  The 
color based representation in Figure 4 can be used for this purpose. This can also be applied to 
mobile phone and other softwares. 
 
DISCUSSION  
 
We have shown that a mathematical model developed to predict the outcome of pregnancies of 
initially unknown viablity maintains its performance when subjected to external validation. We 
have also demonstrated that a new model that does not require knowledge of LMP as a variable 
has reasonable test performance. This is important as our study showed that 20% of women 
with a PUV can not accurately recall the date of their LMP.    
 
Several tools have been described in the literature for predicting the outcome of pregancies of 
uncertain viability, however these usually require both information derived from 
ultrasonography and biochemical parameters. Bignardi et al found that an hCG ratio > 2.0 was 
predictive of a viable pregnancy at 11-14 weeks (13). However this study required two blood 
tests and was based on a population of women initially classifed with pregnancies of unknown 
location.  Another logistic regression model was originally published by Elson et al in 2003 
(14). This model was dependent on maternal demographics and ultrasound features but also 
required  serum  progesterone measurement. This model showed reasonable performance on 
temporal validation with an AUC of 0.85 compared to 0.97 which was the AUC in the original 
study (15). However this study took six years to recruit because over 90% of eligible women 
refused  the test, possibly because of the necessity for blood tests. In routine clinical practice, 
bHCG is not performed for women who are diagnosed as PUV at the initial TVS. Therefore, 
our study was based on simple indicators that would be normally ascertained as part of routine 
clinical practice.  
 
An advantage of the mathematical model Mo and scoring system SSo (9) validated in this paper,  
is that it can provide women with an individualised probability of the viability of their 
pregnancy  at the end of the first trimester, only using demographic information, symptoms and 
TVS findings. Furthermore the risk of miscarriage can be given immediately following their 
examination. For example, a 35 year old woman with a bleeding score of 2 at 48 days gestation 
with an mean gestational sac diameter of 14mm and absent yolk sac has an 18% probability of 
viability at the end of first trimester using the original scoring system SSo, and 13.2% using the 
new model SSn that did not take gestational age into account.  
 
The new statistical model (Mn) and scoring system (SSn) which do not require LMP as a variable 
did not perform as well as the original model (Mo) and scoring system (SSn). However, they 
showed reasonable test performance which was retained on external validation, and so give us 
a tool which we can use in the significant minority of women with uncertain dates.  
 
In comparison to the original study (9), the external validation dataset showed a similar 
miscarriage rate (50% versus 50.7%). Approximately 39.8% women presented with symptoms 
of bleeding compared to 35.5% in the original population. Both the development and external 
validation studies took place in ethnically diverse busy inner city hospitals. The scoring system 
is easy to use and does not require a computer for use (see Figure 4).  The model and scoring 
system can be integrated into any of the commercially available ultrasound reporting programs 
or into a smartphone or tablet application, and so their introduction into clinical practice should 
be straightforward.  
 
At present, a multicenter prospective study is ongoing to better define the cut off levels for 
measurements of mean gestational sac diameter  and CRL that can be used to diagnose 
miscarriage (Diagnosis of Miscarriage (DOM) Study). It is likely that this would support 
recommendations that more women are asked to return for a repeat scan to definitively check 
viability. A reliable estimated probability of the likely outcome of their pregnancy would be 
helpful when counselling these women. In the event of a high likelihood of a viable pregnancy, 
women could be reassured that they do not need close follow up. When the predicted outcome 
is a non-viable pregnancy, women could be warned regarding possible heavy bleeding and 
offered a repeat TVS assessment after an interval of 7 to 14 days.  
 
A very important issue in early pregnancy care is managing the realistic expectations and 
anxieties of women who present with bleeding. Our experience is that when given a choice,  
women prefer to be given an  immediate individualised probability of the likely outcome of 
their pregnancies rather than being given the standard advice that there is a background 50% 
chance of miscarriage for all women with a PUV. A similar study using a predictive model and 
scoring system to predict the chance of  of viability in all women  seen in an early pregnancy 
assessment unit, including those with an embryonic heart beat at initial TVS is also being 
validated at other units to assess its generalisability and patient accepability (17). 
 
Women with bleeding in early pregnancy are invariably anxious about the outcome of their 
pregnancy. Though our outcome measure is the first trimester viability it is a known fact that 
the risk of miscarriage in the 2nd trimester, after a normal dating scan at 11 – 14 weeks, is very 
low (16). We have shown that a prediction model or scoring system to predict viability works 
in different clinical settings. These prediction tools can be introduced into clinical practice to 
both counsel women about the likely outcome of their pregnancy, and offer guidance on 
appropriate follow up arrangements based on the prognosis for that specific  pregnancy.  
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Total consecutive 
pregnancies 
N= 575 
N = 513 
(89.2%) 
Pregnancy outcome unknown 
for 62 patients 
 Total pregnancies analysed 
for Mn  & SSn 
nm = 503 
Total pregnancies analysed 
for Mo & SS0 
no = 400 
Missing Values:
 
 
Unknown bleeding score - 9 
Unknown yolk sac info – 2 
1 patient had both missing 
values 
Patients with missing LMPs: 103 
 Figure 2: ROC curves for the original model (Mo) and scoring system (SSn) on the test set of the original 
paper and the validation set reported in this paper.  These models are validated on the set of 400 
pregnancies with known outcome and all covariates (including known LMP).  Both the model (Mo) and 
the scoring system (SSn) perform well on the independent validation data. 
 
 
 
 
Figure 3:  ROC curves for the new model (Mn) and scoring system (SSn) (not including LMP)  on the test 
set of the original paper and the validation set reported in this paper.  These models are validated on the 
503 pregnancies with known outcome and all covariates, except LMP.  Both the model (Mn) and the 
scoring system (SSn) perform well on the independent validation data.  However, due to the lack of 
information on LMP, the performance is less than for the original model (Mo). 
 
  
 
Figure 4: Graphical representation of the combined model.  Whenever a patient reports an LMP, the left 
part of the graph (original scoring system (SSo)) can be used to obtain an estimated chance on a viable 
pregnancy at the end of the first trimester.  Whenever a patient is not able to report an LMP, the right 
part of the graph (new score system (SSn)) can be used to obtain this chance. 
  
Table 1:  Illustration of the new scoring system (SSn).  All points corresponding to the pregnancy 
characteristics need to be added.  The resulting sum is used to obtain an estimated chance on a viable 
pregnancy by means of the bottom part of the table. 
Variable Points 
Age  
≤ 35 0 
36- 40 1.4 
>40 2.8 
PBAC bleeding score  
0 0 
1 1 
2 2 
3 3 
4 4 
Mean gestational sac 
diameter 
 
<4 mm 0.4 
4 mm -6.9 mm 0 
 7 mm - 9.9 mm 0 
10 mm -12.9 mm 0.4 
 ≥13mm 0.7 
Yolk sac  
present 0 
absent 0.8 
PBAC bleeding score when 
yolk sac is present 
 
0 0 
1 -0.9 
2 -1.8 
3 -2.7 
4 -3.5 
Estimated probability of 
viable pregnancy at the 
end of the first trimester 
 
 
   Score 
 
0.8900 0 
0.7500 1 
0.5100 2 
0.2700 3 
0.1200 4 
0.0500 5 
0.0200 6 
  
 
 
 
 
 
 
